Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)

China flag China · Delayed Price · Currency is CNY
30.15
-0.30 (-0.99%)
Mar 9, 2026, 3:00 PM CST
60.46%
Market Cap 13.35B
Revenue (ttm) 909.54M
Net Income (ttm) 51.08M
Shares Out 442.94M
EPS (ttm) 0.13
PE Ratio 240.81
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,371,708
Average Volume 9,052,662
Open 30.00
Previous Close 30.45
Day's Range 29.15 - 30.45
52-Week Range 14.86 - 44.99
Beta 0.79
RSI 42.12
Earnings Date Mar 31, 2026

About SHA:688321

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research and development of original small molecule drugs. The company develops Chidamide, a subtype-selective histone deacetylase inhibitor for the treatment of peripheral T-cell lymphoma and advanced hormone receptor-positive breast cancer; Chiglitazar Sodium, a PPAR pan-agonist for the treatment of metabolic diseases; and Chiauranib, a triple-pathway tumor-targeting inhibitor. It is also developing CS23546, a small-molecule PD-L1 inhibitor; CS231295, a brain-penetrant Aurora B selectiv... [Read more]

Sector Healthcare
Founded 2001
Employees 973
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688321
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.